Colgate-Palmolive (NYSE:CL) Shares Sold by Cornerstone Advisors LLC

Cornerstone Advisors LLC decreased its position in Colgate-Palmolive (NYSE:CL) by 4.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 37,631 shares of the company’s stock after selling 1,600 shares during the period. Cornerstone Advisors LLC’s holdings in Colgate-Palmolive were worth $3,652,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Gryphon Financial Partners LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $225,000. Foundations Investment Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 9.7% in the fourth quarter. Foundations Investment Advisors LLC now owns 3,124 shares of the company’s stock valued at $269,000 after purchasing an additional 275 shares in the last quarter. Brown Advisory Inc. lifted its holdings in shares of Colgate-Palmolive by 17.3% in the fourth quarter. Brown Advisory Inc. now owns 159,650 shares of the company’s stock valued at $12,726,000 after purchasing an additional 23,560 shares in the last quarter. Hillsdale Investment Management Inc. purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $566,000. Finally, Gladstone Institutional Advisory LLC raised its position in shares of Colgate-Palmolive by 35.8% in the fourth quarter. Gladstone Institutional Advisory LLC now owns 7,686 shares of the company’s stock valued at $613,000 after buying an additional 2,028 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In related news, insider Sally Massey sold 15,850 shares of the stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,490 shares of company stock valued at $4,486,063. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Down 0.3 %

NYSE CL opened at $105.43 on Tuesday. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The company has a market capitalization of $86.50 billion, a price-to-earnings ratio of 33.36, a price-to-earnings-growth ratio of 3.72 and a beta of 0.40. The company’s fifty day moving average price is $102.26 and its two-hundred day moving average price is $95.43.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The company had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm’s revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.77 earnings per share. As a group, research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.90%. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on CL shares. Barclays boosted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Citigroup boosted their price objective on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Stifel Nicolaus upped their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, July 22nd. Finally, Jefferies Financial Group lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $102.79.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.